1-3 of 3
Rachel L Sargent, MD
Close
Sort by
Journal Articles

Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis

Aaron C. Logan, MDPhD, Alex F. Herrera, MD, Christine E. Ryan, Andrew R. Rezvani, MD, Katherine A. Kong, PhD, Malek Faham, MD PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Rachel L. Sargent, MD, Edwin P. Alyea, MD, Vincent T. Ho, MD, Jennifer R. Brown, MD PhD, Jerome Ritz, MD, David B. Miklos, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4340.
https://doi.org/10.1182/blood.V126.23.4340.4340
Published: 2015
Journal Articles

Characteristics and Prognosis of Patients with Aggressive Chronic Lymphocytic Leukemia and Richter's Transformation: Correlation Between FDG/PET, Histology and Clinical Outcomes

Lorenzo Falchi, MD, Long Xuan Trinh, Edith M. Marom, MD, Mylene Truong, MD, Ellen Schlette, MD, Rachel L. Sargent, MD, Xuemei Wang, MS, Susan C. Smith, Susan Lerner, MS, Michael J. Keating, MD, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2012) 120 (21): 927.
https://doi.org/10.1182/blood.V120.21.927.927
Published: 2012
Journal Articles

Final Analysis of a Phase 2 Study of Lenalidomide and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Xavier C Badoux, MBBS, Michael J Keating, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Stefan Faderl, MD, Zeev Estrov, Manolo Pasia, BSN, Susan Lerner, MS, BA, Rachel L Sargent, MD, Hagop M. Kantarjian, MD, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2011) 118 (21): 980.
https://doi.org/10.1182/blood.V118.21.980.980
Published: 2011